Leukocyte ABCA1 gene expression is associated with fasting glucose concentration in normoglycemic men

Adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) mediates the efflux of cholesterol to apolipoprotein A1, a process necessary for high-density lipoprotein (HDL) formation and reverse cholesterol transport. In patients with Tangier disease, mutations in ABCA1 result in low circulating HDL-cholesterol and predisposition to coronary heart disease (CHD). ABCA1 gene expression is decreased in diabetic mice. In humans, glycated hemoglobin (HbA 1c) predicted future CHD events, even within the normal range. We hypothesised that leukocyte ABCA1 gene expression would be inversely associated with indices of glycemia in normoglycemic men. Fasting blood samples were taken from 32 healthy, nonsmoking, normoglycemic men (age 23 to 46 years). ABCA1, peroxisome proliferator-activated receptor gamma ( PPARγ), and liver X receptor alpha ( LXRα) gene expressions in circulating leukocytes were measured using TaqMan technology. Significant inverse associations between ABCA1 gene expression and both fasting glucose concentration ( r = −0.49, P = .008) and age ( r = −0.39, P = .043) were found. There was no association with HbA 1c ( r = −0.23, P = .238) or HDL-cholesterol concentration ( r = 0.02, P = .904). In a multiple regression model, fasting glucose remained a significant independent predictor ( P = .037), whereas age did not ( P = .226). Mechanisms underlying the association were explored; there were no significant associations between fasting glucose concentration and leukocyte PPARγ gene expression, or between fasting glucose concentration and leukocyte LXRα gene expression. This is the first demonstration of an association between ABCA1 gene expression and fasting glucose concentration in vivo.